Product Information
NORTREL 1-35 21 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3379 per EA under NDC 00555900942. Its NADAC has been published 614 times since Nov 28, 2013.
Strength
.035; 1 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555900942
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONEApproval Type
Generic (ANDA)
FDA Application
ANDA072693On Market Since
6/13/2001
Price Statistics
The NADAC for NORTREL 1-35 21 TABLET has been published 614 times since Nov 28, 2013, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3379 per EA |
|---|---|
| All-time high | $0.7514 (Feb 10, 2021) |
| All-time low | $0.2264 (Jun 21, 2023) |
| 52-week high | $0.4218 |
| 52-week low | $0.3379 |
| Median price | $0.4510 |
| Average price | $0.4689 |
| Largest weekly change | +56.2% (Feb 19, 2020) |
| Weeks tracked | 614 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Norethindrone and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NORTREL 1-35 21 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORTREL 1-35 21 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3379 per EA (NDC 00555900942), effective Jun 24, 2026.
How has the price of NORTREL 1-35 21 TABLET changed over time?
Over the history we have for it, the NADAC for NORTREL 1-35 21 TABLET has declined 36.9%. It has been tracked across 614 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORTREL 1-35 21 TABLET?
Since Nov 28, 2013, the NADAC for NORTREL 1-35 21 TABLET has ranged from a low of $0.2264 (Jun 21, 2023) to a high of $0.7514 (Feb 10, 2021), with a median of $0.4510 per EA.
Are there cheaper alternatives to NORTREL 1-35 21 TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NORTREL 1-35 21 TABLET, so no direct lower-cost alternative is listed.
Who manufactures NORTREL 1-35 21 TABLET?
NORTREL 1-35 21 TABLET (NDC 00555900942) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification